Medicines Australia's decision to moderate its celebratory tone on the HTA Review options paper should be welcomed, but the communication needs to go beyond its members, and it needs to stop pushing for a response in the 2024-25 Budget.
If this is the real view, then the onus is on the association to share it more broadly
February 19, 2024 Latest NewsBioPharmaComment
Latest Video
New Stories
-
New Zealand moves again to make it easier to access medicines
July 11, 2025 - - Latest News -
The 'Dispatched' Week in Review Podcast - 10 July
July 10, 2025 - - Podcast -
'The debate is frustrating but it is an opportunity to amplify acknowledged concerns'
July 10, 2025 - - Latest News -
Medibank to subsidise pharmacogenetic testing for members
July 10, 2025 - - Latest News -
Is this the missing link in pharma engagement strategies?
July 9, 2025 - - Latest News -
Stakeholders welcome medicinal cannabis crackdown
July 9, 2025 - - Latest News -
Might Australia be just a little hypocritical on pharmaceutical tariffs?
July 9, 2025 - - Latest News